monoclonal-antibodies

Documents about monoclonal-antibodies

• Acceptability and preferences regarding RSV immunisation during pregnancy: a cross-sectional study in diverse global settings#311941HAL (France)
• Lara V. Marks. The Lock and Key of Medicine: Monoclonal Antibodies and the Transformation of Healthcare. xxv + 316 pp., illus., figs., tables, bibl., index. New Haven, Conn./London: Yale University Press, 2015. $40#715717PhilArchive
• Second-season Impact of Nirsevimab: Clinical Outcomes of RSV Disease in Patients Immunized During Their First Season.#672219Repisalud
• Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers.#190956Apollo
• Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers.#191007Apollo
• Use of Tezepelumab for Chronic Rhinosinusitis with Nasal Polyps by Eosinophilic Endotype: WAYPOINT Post-Hoc Analysis#1001623ODU Digital Commons
• Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults#886337ClinicalTrials.gov
• A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013)#432914ClinicalTrials.gov
• A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome#880780ClinicalTrials.gov
• An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma#968799ClinicalTrials.gov
• Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma#846912ClinicalTrials.gov
• Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)#866047ClinicalTrials.gov
• A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Federation)#848225ClinicalTrials.gov
• FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors#872147ClinicalTrials.gov
• Tezepelumab's Effects on Patient-Reported Symptoms in Severe Asthma, Overall and With History of Comorbid Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)#305445ODU Digital Commons
• Real-life evaluation of the effectiveness of biologics for chronic rhinosinusitis with nasal polyps in Europe: a Delphi study to define key variables for the INVENT registry#1038748Figshare
• Depemokimab: A Twice Yearly Anti-IL 5 Biologic for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) - A Narrative Review#351836ODU Digital Commons
• 5C psychological antecedents of vaccine hesitancy toward maternal RSV vaccines and infant monoclonal antibodies among pregnant and postpartum women and their partners in China: A multicenter, dyadic survey design, cross-sectional study#784386Europe PMC
• Phase I, Open-Label, Dose-Escalation Study of a Human Monoclonal Antibody, VRC-HIVMAB091-00-AB (N6LS), Administered Intravenously or Subcutaneously With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)#995365ClinicalTrials.gov
• A Safety Study of SGN-CD19A for B-Cell Lymphoma#1029735ClinicalTrials.gov
• A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms#899623ClinicalTrials.gov
• Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy#863935ClinicalTrials.gov
• Reply to: S. N. Katkuri et al. and H. Liu et al. on Early and Sustained Improvements in Sense of Smell with Tezepelumab Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyps (WAYPOINT)#215645ODU Digital Commons
• A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.#886504ClinicalTrials.gov
• A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)#870325ClinicalTrials.gov